How government-dependent is DAY ONE BIOPHARMACEUTICALS, INC.?

In fiscal year 2025, US federal contract obligations equal at least 0.0% of DAY ONE BIOPHARMACEUTICALS, INC.'s reported revenue - $25.9k in federal awards against $158.2M in revenue as filed with the SEC. In fiscal year 2024 the share was at least 0.0%.

Cite as: FACTANKER, https://factanker.com/entity/3fabc737-9242-46a5-9725-07bb55fd3ae6/government-dependency

Fiscal yearRevenue (SEC, as filed)Federal obligationsShareData status
FY 2025$158.2M$25.9k≥ 0.0%contracts only
FY 2024$131.2M$0≥ 0.0%contracts only
Evidence
Revenue FY 2025: evidence fact 19e0a542… (SEC filing)
Federal obligations FY 2025: sum of 3 award records (USAspending bulk data)
Identity consolidation: CIK 0001845337 · UEI G9SZJB5MEHR3 - linked via evidence-backed same_as facts, see all facts of this organization
Methodology & sources
Revenue: company fiscal year, as filed with the SEC (XBRL concept per evidence fact). Obligations: US federal fiscal year of the award date, consolidated across all registrations of the corporate group. Computed in the database, precomputed weekly - never by a model. Sources: SEC EDGAR, USAspending (public domain).
Not claimed

DAY ONE BIOPHARMACEUTICALS, INC. - all facts · Use this metric in your own models: JSON/API · API/MCP quickstart